Tech Company Financing Transactions

Base Pair Biotechnologies Funding Round

Base Pair Biotechnologies, based in Pearland, secured $3.2 million from Base Pair Canada, Eventi Capital Partners and BioTex.

Transaction Overview

Company Name
Base Pair Biotechnologies
Announced On
11/29/2017
Transaction Type
Venture Equity
Amount
$3,200,000
Round
Series A
Investors

Base Pair Canada (Lead Investor) (Michele Gowda)

Eventi Capital Partners (Lead Investor) (Scott Bryan)

BioTex (Ashok Gowda)

Proceeds Purpose
Base Pair will use the investment to acquire new lab instruments and other technology that will allow the company to expand its cellular and molecular analysis capabilities, enabling improved methods for finding aptamers that bind targets on and in live cells. The funding will also be used to expand the team, providing additional technical capability and enhancing geographical reach.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8619 Broadway St. 100
Pearland, TX 77584
USA
Phone
(832) 230-5518
Website
www.basepairbio.com
Email Address
[email protected]
Overview
Base Pair Biotechnologies, Inc. is a world-leading provider of highly customized aptamer discovery and development services. The company is five years old, privately held, and located in the Houston, Texas metropolitan area, close to major medical centers and universities.
Profile
Base Pair Biotechnologies LinkedIn Company Profile
Social Media
Base Pair Biotechnologies Company Twitter Account
Company News
Base Pair Biotechnologies News
Facebook
Base Pair Biotechnologies on Facebook
YouTube
Base Pair Biotechnologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Vicki Singer
  Vicki Singer LinkedIn Profile  Vicki Singer Twitter Account  Vicki Singer News  Vicki Singer on Facebook
Chief Scientific Officer
William Jackson
  William Jackson LinkedIn Profile  William Jackson Twitter Account  William Jackson News  William Jackson on Facebook
VP - General Counsel
Christopher Quan
  Christopher Quan LinkedIn Profile  Christopher Quan Twitter Account  Christopher Quan News  Christopher Quan on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/29/2017: Envisagenics venture capital transaction
Next: 11/29/2017: Arzeda venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.